About bigfootpeptides

Why this collection exists

Bigfoot suggests an absent subject: there is a cast to examine, but whose foot made it? The body behind a peptide result interests me. A healthy volunteer, a man in a hair-loss trial and a mouse with experimental colitis enter a study under very different conditions.

The full-length thymosin beta-4 trial begins with healthy volunteers. The rat neurological findings and the GHK skin and hair studies bring other populations and experimental settings into view. A trial can be human and still concern a narrow group of people.

I have no creature sighting to offer. My question is who remains absent from the experiments. Would the result hold in people with a different illness, age or sex? That takes research in those populations. I cannot picture the participants from the word human alone.

What the site offers

bigfootpeptides is a collection of articles about peptide research. It offers no medical service or products, and nothing here is personal medical advice. Treatment decisions require a licensed clinician who can assess the individual circumstances; an article cannot perform that assessment.

The experiments supply my enthusiasm: a fragment separated from a hormone, copper retained in an excised skin layer, a cell changing shape before it moves. Universal repair promises leave me unconvinced. The unresolved safety questions are substantial, particularly where systemic exposure or several substances together are concerned.

Unfinished questions

A correction is especially welcome when it changes the identification, population or measured outcome. A paper's title, DOI or PubMed record and the relevant passage make that possible. The contact page gives the existing editorial address, and references gathers the source list.

A direct study of those exact preparations would please me enormously, especially in a clearly defined patient group. Another attractive mechanism would be enjoyable to explore. It would still leave that experiment to do.